Fig. 6.
Synergisitc cytotoxicity of sCDP/DOX/miR-122 in HepG2 cells. Cell viabilities of HepG2 cells with different treatments for 48 h (a) and 72 h (b) (n = 4).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.